Philips Medical OTC Defibrillator Panel Review Highlights User Hurdles
This article was originally published in The Gray Sheet
Executive Summary
FDA panel members raised concern over potentially harmful interactions between ICDs and Philips Medical's HeartStart Home automatic external defibrillators while reviewing an over-the-counter claim for the AED
You may also be interested in...
Philips Gets FDA Nod For First OTC Defibrillator, Plans TV/Print Ad Campaign
Philips Medical expects its HeartStart Home non-prescription AED to become increasingly affordable for consumers as production volume ramps up
Philips Gets FDA Nod For First OTC Defibrillator, Plans TV/Print Ad Campaign
Philips Medical expects its HeartStart Home non-prescription AED to become increasingly affordable for consumers as production volume ramps up
Defibrillation Begins At Home, Study Authors Find; Philips Opens Toolkit
A dearth of on-site responders and AEDs in the home setting prevents rapid defibrillation for the majority of patients susceptible to cardiac arrest, study and editorial authors write in the Aug. 12 New England Journal of Medicine